These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37533127)

  • 41. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial.
    Hoke AM; Rosen P; Pileggi F; Molinari A; Sekhar DL
    Res Involv Engagem; 2023 Mar; 9(1):17. PubMed ID: 36978148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and evaluation of a parent advisory group to inform a research program for knowledge translation in child health.
    Hartling L; Elliott SA; Buckreus K; Leung J; Scott SD
    Res Involv Engagem; 2021 Jun; 7(1):38. PubMed ID: 34099069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study.
    Bartlett SR; Wong S; Yu A; Pearce M; MacIsaac J; Nouch S; Adu P; Wilton J; Samji H; Clementi E; Velasquez H; Jeong D; Binka M; Alvarez M; Wong J; Buxton J; Krajden M; Janjua NZ
    Clin Infect Dis; 2022 Mar; 74(4):575-583. PubMed ID: 34125883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-building a training programme to facilitate patient, family and community partnership on research grants: A patient-oriented research project.
    Nielssen I; Ahmed S; Zelinsky S; Dompe B; Fairie P; Santana MJ
    Health Expect; 2023 Aug; 26(4):1584-1595. PubMed ID: 37078644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "It's Like A Partnership": Exploring the Primary Care Experiences and Patient-Defined Goals of People Who Use Drugs.
    Dunham K; Rivas C; Medina Blanco P; Kolod B; Salvati C; Clark K; Sue KL; Hagaman A; Weiss JJ
    J Gen Intern Med; 2024 Jul; 39(9):1681-1689. PubMed ID: 38578536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enablers and barriers for the provision of community-based HCV treatment: A case study of a real-world practice.
    Pourmarzi D; Smirnov A; Hall L; Thompson H; FitzGerald G; Rahman T
    J Viral Hepat; 2020 May; 27(5):484-496. PubMed ID: 31958355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.
    Coupland H; White B; Bates A; Park JN; Iversen J; Maher L
    Drug Alcohol Rev; 2019 Feb; 38(2):177-184. PubMed ID: 30652363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protocol for co-producing a framework and integrated resource platform for engaging patients in laboratory-based research.
    Lalu MM; Richards D; Foster M; French B; Crawley AM; Fiest KM; Hendrick K; Macala KF; Mendelson AA; Messner P; Nicholls SG; Presseau J; Séguin CA; Sullivan P; Thébaud B; Fergusson DA
    Res Involv Engagem; 2024 Feb; 10(1):25. PubMed ID: 38347658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service.
    Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ
    J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pilot study of a mixed-method approach to design an ED-based peer mHealth referral tool for HIV/HCV and opioid overdose prevention services.
    Knaub RJ; Evans J; Yang C; Roura R; McGinn T; Verschoore B; Ricketts EP; Rothman RE; Latkin CA; Hsieh YH
    Drug Alcohol Depend; 2022 Sep; 238():109585. PubMed ID: 35926299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Telehealth in school-based practice: Perceived viability to bridge global OT practitioner shortages prior to COVID-19 global health emergency.
    Abbott-Gaffney C; Jacobs K
    Work; 2020; 67(1):29-35. PubMed ID: 32925151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium.
    Busschots D; Kremer C; Bielen R; Koc ÖM; Heyens L; Dercon E; Verrando R; Windelinckx T; Maertens G; Bourgeois S; Hens N; Matheï C; Robaeys G
    Harm Reduct J; 2021 May; 18(1):54. PubMed ID: 34001145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping for Engagement: Setting up a Community Based Participatory Research Project to Reach Underserved Communities at Risk for Hepatitis C in Ho Chi Minh City, Vietnam.
    Nguyen Quoc G; Nguyen Le Thao M; Bao A; Nguyen Anh N; Vu Thi Tuong V; Nguyen Thi Ngoc D; Phan L; Phan Minh T; Lam Ngoc T; Nguyen Thanh A; Nguyen Anh T; Nguyen Nguyen Nhu T; Nguyen Thi L; Nguyen Thuy Thanh V; Nguyen Minh H; Nguyen Minh T; Do Thuy An M; Nguyen Tri T; Tran Thi P; Pham Hong S; Tran Thi N; Hoang Thai A; Duong Thi My H; Cooke GS; Chambers M; Van Nuil JI
    Front Public Health; 2022; 10():795470. PubMed ID: 35223733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
    Treloar C; Rance J;
    Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "When people who use drugs can't differentiate between medical care and cops, it's a problem." Compounding risks of law Enforcement Harassment & Punitive Healthcare Policies.
    Ostrach B; Hixon V; Bryce A
    Health Justice; 2024 Feb; 12(1):3. PubMed ID: 38319474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver health events: an indigenous community-led model to enhance HCV screening and linkage to care.
    Pandey M; Konrad S; Reed N; Ahenakew V; Isbister P; Isbister T; Gallagher L; Campbell T; Skinner S
    Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34125199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.
    Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A
    Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C.
    Nagot N; D'Ottavi M; Quillet C; Debellefontaine A; Castellani J; Langendorfer N; Hanslik B; Guichard S; Baglioni R; Faucherre V; Tuaillon E; Pageaux GP; Laureillard D; Donnadieu-Rigole H
    Open Forum Infect Dis; 2022 Jun; 9(6):ofac181. PubMed ID: 35774932
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.